蒲公英 - 制药技术的传播者 GMP理论的实践者

搜索
查看: 4732|回复: 10
收起左侧

[风险管理] 关于原辅料的检验频次和内容的一些规定

[复制链接]
药徒
发表于 2015-9-16 19:16:41 | 显示全部楼层 |阅读模式

欢迎您注册蒲公英

您需要 登录 才可以下载或查看,没有帐号?立即注册

x
有一天开会提到一个问题是否可以减少进场原辅料的检验频次和内容。因为我们现在的进场原辅料实在是太多,而且由于生产计划和采购计划的不协调导致所有的压力都在QC和仓库。后来上网搜索了一下发现了一些端倪,共享给大家学习一下。但是中外的差异还是很大的。
FDA和ICH相关条文

21 CFR Section 211.84(d):
(d) Samples shall be examined and tested as follows:

(1) At least one test shall be conducted to verify the identity of each component of a drug product. Specific identity tests, if they exist, shall be used.

(2) Each component shall be tested for conformity with all appropriate written specifications for purity, strength, and quality. In lieu of such testing by the manufacturer, a report of analysis may be accepted from the supplier of a component, provided that at least one specific identity test is conducted on such component by the manufacturer, and provided that the manufacturer establishes the reliability of the supplier's analyses through appropriate validation of the supplier's test results at appropriate intervals.

(3) Containers and closures shall be tested for conformity with all appropriate written specifications. In lieu of such testing by the manufacturer, a certificate of testing may be accepted from the supplier, provided that at least a visual identification is conducted on such containers/closures by the manufacturer and provided that the manufacturer establishes the reliability of the supplier's test results through appropriate validation of the supplier's test results at appropriate intervals.

(4) When appropriate, components shall be microscopically examined.

(5) Each lot of a component, drug product container, or closure that is liable to contamination with filth, insect infestation, or other extraneous adulterant shall be examined against established specifications for such contamination.

(6) Each lot of a component, drug product container, or closure with potential for microbiological contamination that is objectionable in view of its intended use shall be subjected to microbiological tests before use.

ICH Q 7

7.30 At least one test to verify the identity of each batch of material should be conducted, with the exception of the materials described below in

7.32. A supplier's Certificate of Analysis can be used in place of performing other tests, provided that the manufacturer has a system in place to evaluate suppliers.

7.31 Supplier approval should include an evaluation that provides adequate evidence (e.g., past quality history) that the manufacturer can consistently provide material meeting specifications. Full analyses should be conducted on at least three batches before reducing in-house testing. However, as a minimum, a full analysis should be performed at appropriate intervals and compared with the Certificates of Analysis. Reliability of Certificates of Analysis should be checked at regular intervals.

7.32 Processing aids, hazardous or highly toxic raw materials, other special materials, or materials transferred to another unit within the company’s control do not need to be tested if the manufacturer’s Certificate of Analysis is obtained, showing that these raw materials conform to established specifications. Visual examination of containers, labels, and recording of batch numbers should help in establishing the identity of these materials. The lack of on-site testing for these materials should be justified and documented.


也就是说,如果经过前三批的全检之后,经过风险评估是可以根据自己的实际情况部分检验,但是部分检验中必须是要有至少一个鉴别的。然后隔一段时间做一次全检即可。


但是国内的要求又有不同


GMP第二百二十三条:“物料和不同生产阶段产品的检验应当至少符合以下要求:(一)企业应当确保药品按照注册批准的方法进行全项检验。”这里物料指的是原料、辅料和包装材料。所以企业应对直接接触药品的包装材料进行全项检测,如你企业有些检测实在无法做到,可以按有关规定进行委托检测。但你企业应对检测承担责任。


也就是说国内的GMP要求进场原辅料必须按照注册标准进行全检。
回复

使用道具 举报

药师
发表于 2015-9-16 19:22:45 | 显示全部楼层
国外是建立在互相信任的基础上的代表性检验。
国内是建立在互相不信任的基础上的全检。

点评

恩,是这样。所以国外那样做是有道理的,有些事情国内行不通。  发表于 2015-9-17 07:28
回复

使用道具 举报

药徒
 楼主| 发表于 2015-9-16 22:11:30 | 显示全部楼层
石头968 发表于 2015-9-16 19:22
国外是建立在互相信任的基础上的代表性检验。
国内是建立在互相不信任的基础上的全检。

哎 是啊,老外对于审计是首先认为你是守信的
而国内首先就认为你会作假

点评

法系不一样,有罪推论和无罪推论  详情 回复 发表于 2015-9-17 08:55
回复

使用道具 举报

发表于 2015-9-17 07:35:31 | 显示全部楼层
这一条在国内是没的商量的,不要想着生产厂家全检后就能自己不需要把严关了,我们当年就是在这里掉坑被记缺陷了,导致如今还时常有人来公司抽检原辅料。
回复

使用道具 举报

药徒
发表于 2015-9-17 08:27:41 | 显示全部楼层
原辅料是要求全检的呢,包装材料可以部分检验。
回复

使用道具 举报

药师
发表于 2015-9-17 08:55:35 | 显示全部楼层
gmp-qc 发表于 2015-9-16 22:11
哎 是啊,老外对于审计是首先认为你是守信的
而国内首先就认为你会作假

法系不一样,有罪推论和无罪推论
回复

使用道具 举报

发表于 2017-4-11 14:34:29 | 显示全部楼层
★风★ 发表于 2015-9-17 08:27
原辅料是要求全检的呢,包装材料可以部分检验。

这里的全检,怎么理解呢?比如说我的原料是一桶一桶来的,从每桶里面抽出一部分?

点评

全检的原辅料的检验项目全部都需要检验,不是说你来的物料需要全部都要取样检验。  发表于 2017-4-11 20:10
回复

使用道具 举报

药徒
发表于 2021-10-9 17:25:34 | 显示全部楼层
赚钱不容易啊
回复

使用道具 举报

药神
发表于 2023-2-28 18:42:01 | 显示全部楼层
谢谢分享。
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

×发帖声明
1、本站为技术交流论坛,发帖的内容具有互动属性。您在本站发布的内容:
①在无人回复的情况下,可以通过自助删帖功能随时删除(自助删帖功能关闭期间,可以联系管理员微信:8542508 处理。)
②在有人回复和讨论的情况下,主题帖和回复内容已构成一个不可分割的整体,您将不能直接删除该帖。
2、禁止发布任何涉政、涉黄赌毒及其他违反国家相关法律、法规、及本站版规的内容,详情请参阅《蒲公英论坛总版规》。
3、您在本站发表、转载的任何作品仅代表您个人观点,不代表本站观点。不要盗用有版权要求的作品,转贴请注明来源,否则文责自负。
4、请认真阅读上述条款,您发帖即代表接受上述条款。

QQ|手机版|蒲公英|ouryao|蒲公英 ( 京ICP备14042168号-1 )  京ICP证150354号  互联网药品信息服务证书编号: (京)-非经营性-2024-0033

GMT+8, 2024-9-20 11:46

Powered by Discuz! X3.4运维单位:苏州豚鼠科技有限公司

Copyright © 2001-2020, Tencent Cloud.

声明:蒲公英网站所涉及的原创文章、文字内容、视频图片及首发资料,版权归作者及蒲公英网站所有,转载要在显著位置标明来源“蒲公英”;禁止任何形式的商业用途。违反上述声明的,本站及作者将追究法律责任。
快速回复 返回顶部 返回列表